Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease Recapture Rates After Medication Discontinuation and Flare in Juvenile Idiopathic Arthritis: An Observational Study Within the Childhood Arthritis and Rheumatology Research Alliance Registry.
Ringold S, Dennos AC, Kimura Y, Beukelman T, Shrader P, Phillips TA, Kohlheim M, Schanberg LE, Yeung RSM, Horton DB; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Ringold S, et al. Among authors: shrader p. Arthritis Care Res (Hoboken). 2023 Apr;75(4):715-723. doi: 10.1002/acr.24994. Epub 2022 Dec 21. Arthritis Care Res (Hoboken). 2023. PMID: 35921198
Effectiveness and Safety of High-Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance.
Correll CK, Shrader P, Dennos A, Phillips T, Shiff NJ, Verstegen RHJ, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators. Correll CK, et al. Among authors: shrader p. Arthritis Care Res (Hoboken). 2022 Nov;74(11):1770-1779. doi: 10.1002/acr.24727. Epub 2022 Jul 31. Arthritis Care Res (Hoboken). 2022. PMID: 34121344
Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study.
Verstegen RHJ, Shrader P, Balevic SJ, Beukelman T, Correll C, Dennos A, Phillips T, Feldman BM; CARRA Registry Investigators. Verstegen RHJ, et al. Among authors: shrader p. Arthritis Care Res (Hoboken). 2023 Feb;75(2):410-422. doi: 10.1002/acr.24859. Epub 2022 Nov 11. Arthritis Care Res (Hoboken). 2023. PMID: 35040593
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Steinberg BA, Shrader P, Kim S, Thomas L, Fonarow GC, Ansell J, Kowey PR, Singer DE, Gersh BJ, Mahaffey KW, Peterson ED, Piccini JP; ORBIT-AF Investigators and Patients. Steinberg BA, et al. Among authors: shrader p. Am Heart J. 2016 Nov;181:145-152. doi: 10.1016/j.ahj.2016.07.026. Epub 2016 Aug 27. Am Heart J. 2016. PMID: 27823686 Free article.
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.
Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP; ORBIT-AF Investigators and Patients. Steinberg BA, et al. Among authors: shrader p. J Am Coll Cardiol. 2016 Dec 20;68(24):2597-2604. doi: 10.1016/j.jacc.2016.09.966. J Am Coll Cardiol. 2016. PMID: 27978942 Free article. Clinical Trial.
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS, Shrader P, Fonarow GC, Allen LA, Piccini JP, Peterson ED, Thomas L, Kowey PR, Gersh BJ, Mahaffey KW. Cherian TS, et al. Among authors: shrader p. Am J Cardiol. 2017 Jun 1;119(11):1763-1769. doi: 10.1016/j.amjcard.2017.02.050. Epub 2017 Mar 16. Am J Cardiol. 2017. PMID: 28416199 Free article. Clinical Trial.
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study.
Inohara T, Shrader P, Pieper K, Blanco RG, Thomas L, Singer DE, Freeman JV, Allen LA, Fonarow GC, Gersh B, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Steinberg BA, Peterson ED, Piccini JP. Inohara T, et al. Among authors: shrader p. JAMA Cardiol. 2018 Jan 1;3(1):54-63. doi: 10.1001/jamacardio.2017.4665. JAMA Cardiol. 2018. PMID: 29128866 Free PMC article.
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Jackson LR 2nd, Kim S, Shrader P, Blanco R, Thomas L, Ezekowitz MD, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, Mahaffey KW, Hylek EM, Peterson ED, Piccini JP Sr. Jackson LR 2nd, et al. Among authors: shrader p. J Thromb Thrombolysis. 2018 Nov;46(4):435-439. doi: 10.1007/s11239-018-1715-1. J Thromb Thrombolysis. 2018. PMID: 30051164 Free PMC article.
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry.
Pandey A, Gersh BJ, McGuire DK, Shrader P, Thomas L, Kowey PR, Mahaffey KW, Hylek E, Sun S, Burton P, Piccini J, Peterson E, Fonarow GC. Pandey A, et al. Among authors: shrader p. JACC Clin Electrophysiol. 2016 Jun;2(3):355-363. doi: 10.1016/j.jacep.2015.12.001. Epub 2015 Dec 9. JACC Clin Electrophysiol. 2016. PMID: 29766895 Free article.
107 results